1 in 5 patients with a stent placed for treatment of Coronary Artery Disease experience a Major Adverse Event in 2 Years*
adverse events are due to high risk areas left untreated
adverse events are due to failures at stent sites
*LRP Study: Lancet 2019 Over 2 years, cumulative MACE due to culprit or stented lesions was 9%, non-culprit or untreated lesions was 9%, and indeterminate location was 2%
There is a need to aid interventional cardiologists in optimal stent intervention and identify patients and plaques at risk of future coronary adverse events.
Current technologies aid in stenting optimization, or assess a subset of patient and plaque coronary event risk. Patients need more.
SpectraWAVE’s Medical Imaging Platform is a state-of-the-art integration of proven imaging technologies
into one easy to use system
The patient and the plaque
The highest quality combination of structure and content in one system
Strategize, prepare, confirm and adjust medical therapy